跳至主要内容

Development and Validation of RP-UPLC Method for the Determination of Iloperidone, Its Related Compounds and Degradation Products in Bulk and Dosage Form

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=50970#.VFG4IFfHRK0

A rapid, specific, sensitive, and precise reverse-phase UPLC method developed for the quantitative determination of an atypical antipsychotic drug Iloperidone and its eight potential impurities in drug substances and drug products is described in this report. Chromatographic separation was achieved on a Waters Acquity UPLC® HSS C18 (2.1 mm × 100 mm, 1.8 micron) column thermostated at 35°C with a short runtime of 10 min. Quantification is achieved with photodiode array detection at 225 nm over the concentration range of 0.03 - 0.15 μg/mL. Forced degradation study was carried out under acidic, alkaline, oxidative, photolytic and thermal conditions to demonstrate the stability-indicating capability of the developed UPLC method. Comparison of system performance with conventional high-performance liquid chromatography is made with respect to analysis time, efficiency, and sensitivity. The method is validated according to the ICH guidelines and is applied successfully for the determination of Iloperidone in tablets.
Cite this paper
Landge, S. , Jadhav, S. , Vishwambar, S. , Solanki, P. , Bembalkar, S. and Mathad, V. (2014) Development and Validation of RP-UPLC Method for the Determination of Iloperidone, Its Related Compounds and Degradation Products in Bulk and Dosage Form. American Journal of Analytical Chemistry, 5, 969-981. doi: 10.4236/ajac.2014.514104. 
 

[1] Wren, S.A.C. and Tchelitcheff, P. (2006) Use of Ultra-Performance Liquid Chromatography in Pharmaceutical Development. Journal of Chromatography A, 1119, 140-146.
[2] Snyder, L.R., Kirkland, J.J. and Dolan, J.W. (1997) Introduction to Modern Liquid Chromatography.
[3] Weiden, P.J. (2012) Iloperidone for the Treatment of Schizophrenia: An Updated Clinical Review. Clinical Schizophrenia & Related Psychoses, 34-44.
[4] Center for Drug Evaluation and Research (2009) NDA Approval Letter. Application Number 22-192.
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022192s000_Approv.pdf
[5] Bishop, J.R. and Bishop, D.L. (2010) Iloperidone for the Treatment of Schizophrenia. Drugs, 46, 567-579.
[6] Arif, S.A. and Mitchell, M.M. (2011) Iloperidone: A New Drug for the Treatment of Schizophrenia. American Journal of Health-System Pharmacy, 68, 301-308.
[7] Nakano, M., Kitano, S., Nanri, M. and Kiniwa, M. (2011) Iloperidone, a Unique Histamine H2-Receptor Antagonist, Inhibits Distention-Induced Gastric Acid Secretion through an H2 Receptor-Independent Mechanism. European Journal of Pharmacology, 658, 236-241.
[8] Dewan, B. and Philipose, N. (2011) Iloperidone 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial. Gastroenterology Research and Practice, 2011, Article ID: 640685.
[9] Shimatani, T., Inoue, M., Kuroiwa, T., Xu, J., Nakamura, M., Tazuma, S., Ikawa, K. and Morikawa, N. (2006) Iloperidone, a Newly Developed Antiulcer Drug, Elevates Postprandial Intragastric pH and Increases Plasma Calcitonin Gene-Related Peptide and Somatostatin Concentrations in Humans: Comparisons with Famotidine. Digestive Diseases and Sciences, 51, 114-120.
http://dx.doi.org/10.1007/s10620-006-3094-2
[10] Snyder, L.R., Kirkland, J.J. and Glajch, J.L. (1997) Practical HPLC Method Development. 2nd Edition.
http://dx.doi.org/10.1002/9781118592014
[11] Wu, L.L., Zhang, Z.J., Tian, Y., Li, W., Xu, F.G., Chen, Y. and Wei, H.L. (2005) Determination of Lafutidine in Human Plasma by High-Performance Liquid Chromatography-Electrospray Ionization Mass Spectrometry: Application to a Bioequivalence Study. Journal of Mass Spectrometry, 40, 1637-1643.
http://dx.doi.org/10.1002/jms.942
[12] Chen, W.D., Liang, Y., Li, H., Xiong, Y., Liu, X., Wang, G.J. and Xie, L. (2006) Simple, Sensitive and Rapid LC-ESI-MS Method for the Quantitation of Iloperidone in Human Plasma-Application to Pharmacokinetic Studies. Journal of Pharmaceutical and Biomedical Analysis, 41, 256-260.
http://dx.doi.org/10.1016/j.jpba.2005.10.008
[13] Mutlib, A.E., Strupczewski, J.T. and Chesson, S.M. (1995) Application of Hyphenated LC/NMR and LC/MS Techniques in Rapid Identification of in Vitro and in Vivo Metabolites of Iloperidone. Drug Metabolism and Disposition, 23, 951-964.
[14] Mandpe, L.P. and Pokharkar, V.B. (2011) Stress Degradation Studies on Iloperidone and Development of a Stability Indicating HPLC Method for Bulk Drug and Pharmaceutical Dosage Form. Der Chemica Sinica, 2, 230-239.
[15] Sumithra, M., Sundaram, P.S. and Srinivasulu, K. (2011) Analytical Method Development and Validation of Iloperidone in Tablet Dosage form by RP-HPLC. International Journal of ChemTech Research, 3, 1403-1407.
[16] Chhalotiya, U.K., Bhatt, K.K., Shah, D.A. and Patel, J.R. (2012) Liquid Chromatographic Method for the Quantification of Antipsychotic Agent Iloperidone in Pharmaceutical Formulation. ISRN (International Scholarly Research Network) Analytical Chemistry, 2012, Article ID: 963276.
[17] Manjula Devi, A.S. and Ravi, T.K. (2012) Validation of UV Spectrophotometric and HPLC Methods for Quantitative Determination of Iloperidone in Pharmaceutical Dosage Form. International Journal of PharmTech Research, 4, 576-581.
[18] Saravanan, G., Yunoos, M. and Shahanaz, S.K. (2013) A Validated Reverse Phase High Performance Liquid Chromatographic Assay Method for the Estimation of Iloperidone in Bulk and Commercial Tablet Dosage Form. Journal of Chemical and Pharmaceutical Research, 5, 506-511.
[19] Solanki, P.V., Uppelli, S.B., Pandit, B.S. and Mathad, V.T. (2014) Improved and Efficient Process for the Production of Highly Pure Iloperidone: A Psychotropic Agent. Organic Process Research and Development, 18, 342-348.
http://dx.doi.org/10.1021/op400335p
[20] The United States Pharmacopeia (2009) Validation of Compendial Methods. 36th Edition (USP 36), Rockville.
[21] International Federation of Pharmaceutical Manufactures & Associations (IFPMA) (1996) Validation of Analytical Procedure. International Conference on Harmonization (ICH), Methodology Q2(R1), Geneva.
[22] Ruan, J., Tattersall, P., Lozano, R. and Shah, P. (2006) The Role of Forced Degradation Studies in Stability Indicating HPLC Method Development. American Pharmaceutical Review, 9, 46-53.
[23] Bakshi, M. and Singh, S. (2002) Development of Validated Stability-Indicating Assay Methods—Critical Review. Journal of Pharmaceutical and Biomedical Analysis, 28, 1011-1040.
http://dx.doi.org/10.1016/S0731-7085(02)00047-X
[24] Carstensen, J.T. and Rhodes, C.T. (2000) Drug Stability Principles and Practices. 3rd Edition, Marcel Dekker, New York.          eww141030lx
标签：

评论

发表评论

此博客中的热门博文

Does Immigration Promote the Investment of the Monopolistic Firm?

In the present paper, we examine the effect of increasing uncertainty of immigrants’ growth on the optimal timing of investment of a firm that has a monopolistic power over the labor market. It is revealed that when the uncertainty of immigrants’ growth is more than a threshold level, increasing uncertainty of immigrants’ growth accelerates the optimal timing of firms’ investment and enhances the economic growth, even if the uncertainty of immigrants’ growth is formulated by the geometric Brownian motion, which is in sharp contrast to the standard result that an increase in the uncertainty postpones the optimal timing. With an increase in the immigrants over the past ten years, workforces in the host countries have been growing significantly to the extent that the immigrants represent 70% of the increase in the workforce in Europe, and 47% in the United States as OECD indicates. In the present paper, we attempted to investigate the effect of increased uncertainty caused by the growi...
发表评论
阅读全文

Education Policy Implementation: A Mechanism for Enhancing Primary Education Development in Zanzibar

Education is one of the fundamental rights of individuals; therefore, the government of a country needs to develop and strengthen educational policy and quality as well as to ensure that everyone has equal access to basic education. The improvement of access and quality of education in the world is becoming as an essential factor in development, whereas the basic education (primary school), is acknowledged as a foundation of the higher educational development for every country. To fulfill this goal, governments introduce several policies and procedures; however, it requires some reforms and participation from the politician, policymakers, and other stakeholders to re-examine educational policy so that it can lead to multiplication and betterment of the reforms. Educational reforms actually focus on accountability. A positive educational development and reform is very challenging and needs more effort and strategy on how to use and utilize the resources effectively as such it can achie...
发表评论
阅读全文